Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	costamere	ANK2 ANK3 CMYA5	1.16e-04	22	91	3	GO:0043034
HumanPheno	Hyperactivity	PNKP CUX2 KMT2B ANK3 AP1G1 NFIA CABP4 ASH1L RREB1 SRRM2 SPEN SLC1A4 RSRC1	1.38e-05	558	32	13	HP:0000752
HumanPheno	Disinhibition	PNKP CUX2 KMT2B ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L RREB1 SRRM2 CHAMP1 SPEN SLC1A4 RSRC1	3.47e-05	807	32	15	HP:0000734
HumanPheno	Inappropriate behavior	PNKP CUX2 KMT2B ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L RREB1 SRRM2 CHAMP1 SPEN SLC1A4 RSRC1	3.47e-05	807	32	15	HP:0000719
HumanPheno	Abnormal response to social norms	PNKP CUX2 KMT2B ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L RREB1 SRRM2 CHAMP1 SPEN SLC1A4 RSRC1	3.47e-05	807	32	15	HP:5200123
HumanPheno	Social disinhibition	PNKP CUX2 KMT2B ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L RREB1 SRRM2 CHAMP1 SPEN SLC1A4 RSRC1	3.47e-05	807	32	15	HP:5200029
HumanPheno	Restricted or repetitive behaviors or interests	CUX2 ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L CHAMP1 SPEN SLC1A4	5.23e-05	368	32	10	HP:0031432
HumanPheno	Perseverative thought	CUX2 ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L CHAMP1 SPEN SLC1A4	6.44e-05	377	32	10	HP:0030223
HumanPheno	Disordered formal thought process	CUX2 ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L CHAMP1 SPEN SLC1A4	7.87e-05	386	32	10	HP:0025769
HumanPheno	Abnormally increased volition	PNKP CUX2 KMT2B ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L RREB1 SRRM2 CHAMP1 SPEN SLC1A4 RSRC1	8.49e-05	869	32	15	HP:5200263
HumanPheno	Abnormal thought pattern	CUX2 ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L CHAMP1 SPEN SLC1A4	1.16e-04	404	32	10	HP:5200269
HumanPheno	Abnormal social development	PNKP CUX2 KMT2B ANK3 AP1G1 NFIA ASXL3 CABP4 ASH1L RREB1 SRRM2 CHAMP1 SPEN SLC1A4 RSRC1	1.43e-04	908	32	15	HP:0025732
HumanPheno	Motor stereotypy	CUX2 ANK3 ASXL3 CABP4 ASH1L CHAMP1 SPEN SLC1A4	2.49e-04	280	32	8	HP:0000733
HumanPheno	Large face	KMT2B NFIA APC NHS CCDC115 RREB1 CHAMP1 SPEN	2.68e-04	283	32	8	HP:0100729
Domain	Post-SET_dom	SETDB1 KMT2B ASH1L	5.23e-05	16	87	3	IPR003616
Domain	PostSET	SETDB1 KMT2B ASH1L	5.23e-05	16	87	3	SM00508
Domain	POST_SET	SETDB1 KMT2B ASH1L	5.23e-05	16	87	3	PS50868
Domain	LRRC37AB_C	LRRC37A LRRC37A2	1.28e-04	4	87	2	PF14914
Domain	LRRC37_N	LRRC37A LRRC37A2	1.28e-04	4	87	2	IPR032754
Domain	LRRC37AB_C	LRRC37A LRRC37A2	1.28e-04	4	87	2	IPR029423
Domain	LRRC37	LRRC37A LRRC37A2	1.28e-04	4	87	2	PF15779
Domain	LRRC37A/B-like	LRRC37A LRRC37A2	1.28e-04	4	87	2	IPR015753
Domain	RPEL	MRTFB PHACTR3	4.44e-04	7	87	2	PS51073
Domain	RPEL	MRTFB PHACTR3	4.44e-04	7	87	2	PF02755
Domain	RPEL	MRTFB PHACTR3	4.44e-04	7	87	2	SM00707
Domain	RPEL_repeat	MRTFB PHACTR3	4.44e-04	7	87	2	IPR004018
Domain	FHA_dom	PNKP MDC1 MKI67	6.24e-04	36	87	3	IPR000253
Domain	-	PNKP MDC1 MKI67	6.24e-04	36	87	3	2.60.200.20
Domain	ZU5	ANK2 ANK3	7.56e-04	9	87	2	SM00218
Domain	SET	SETDB1 KMT2B ASH1L	9.16e-04	41	87	3	PF00856
Domain	ZU5	ANK2 ANK3	9.42e-04	10	87	2	PS51145
Domain	SET	SETDB1 KMT2B ASH1L	1.28e-03	46	87	3	SM00317
Domain	RABBD	SYTL1 RPH3A	1.37e-03	12	87	2	PS50916
Domain	ZU5	ANK2 ANK3	1.37e-03	12	87	2	PF00791
Domain	ZU5_dom	ANK2 ANK3	1.37e-03	12	87	2	IPR000906
Domain	Rab_BD	SYTL1 RPH3A	1.37e-03	12	87	2	IPR010911
Domain	WW	BAG3 FNBP4 CEP164	1.45e-03	48	87	3	SM00456
Domain	SET_dom	SETDB1 KMT2B ASH1L	1.63e-03	50	87	3	IPR001214
Domain	SET	SETDB1 KMT2B ASH1L	1.63e-03	50	87	3	PS50280
Domain	WW_DOMAIN_2	BAG3 FNBP4 CEP164	1.73e-03	51	87	3	PS50020
Domain	WW_DOMAIN_1	BAG3 FNBP4 CEP164	1.73e-03	51	87	3	PS01159
Domain	WW_dom	BAG3 FNBP4 CEP164	1.83e-03	52	87	3	IPR001202
Domain	SMAD_FHA_domain	PNKP MDC1 MKI67	1.83e-03	52	87	3	IPR008984
Domain	Hemopexin_CS	MMP10 PRG4	2.79e-03	17	87	2	IPR018486
Domain	Synaptotagmin	SYTL1 RPH3A	3.86e-03	20	87	2	IPR001565
Domain	Hemopexin-like_dom	MMP10 PRG4	5.09e-03	23	87	2	IPR000585
Domain	Hemopexin-like_repeat	MMP10 PRG4	5.09e-03	23	87	2	IPR018487
Domain	Hemopexin	MMP10 PRG4	5.09e-03	23	87	2	PF00045
Domain	HEMOPEXIN	MMP10 PRG4	5.09e-03	23	87	2	PS00024
Domain	-	MMP10 PRG4	5.09e-03	23	87	2	2.110.10.10
Domain	TUDOR	SETDB1 AKAP1	5.09e-03	23	87	2	PS50304
Domain	HEMOPEXIN_2	MMP10 PRG4	5.09e-03	23	87	2	PS51642
Domain	HX	MMP10 PRG4	5.09e-03	23	87	2	SM00120
Domain	Znf_PHD-finger	KMT2B ASH1L NFX1	5.98e-03	79	87	3	IPR019787
Domain	TUDOR	SETDB1 AKAP1	6.98e-03	27	87	2	SM00333
Domain	AT_hook	KMT2B ASH1L	6.98e-03	27	87	2	SM00384
Domain	AT_hook_DNA-bd_motif	KMT2B ASH1L	6.98e-03	27	87	2	IPR017956
Domain	DEATH	ANK2 ANK3	6.98e-03	27	87	2	SM00005
Domain	FHA	MDC1 MKI67	7.49e-03	28	87	2	SM00240
Domain	Tudor	SETDB1 AKAP1	8.57e-03	30	87	2	IPR002999
Domain	FHA_DOMAIN	MDC1 MKI67	9.14e-03	31	87	2	PS50006
Domain	FHA	MDC1 MKI67	9.14e-03	31	87	2	PF00498
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NRBP1 ZC3H11A GTF3C2 CDK12 BAG3 MKI67 APC NUCKS1 NHS PLEKHA6 RAB11FIP1 SRRM2 WNK1 CHAMP1 SPEN	5.73e-12	503	93	15	16964243
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA6 ZC3H11A ZEB1 KMT2B NFIA CDK12 MDC1 BAG3 FNBP4 MKI67 NUCKS1 RREB1 SRRM2 CHAMP1 SPEN AKAP1 PRG4	2.42e-11	774	93	17	15302935
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA6 ZC3H11A UBE2O MRTFB KMT2B ANK3 GTF3C2 CDK12 MDC1 BAG3 FNBP4 CHAMP1 SPEN	2.69e-09	549	93	13	38280479
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	NRDE2 NIFK PNKP ZC3H11A MRTFB KMT2B GTF3C2 AP1G1 CDK12 MDC1 NFX1 APC PALM3 GON4L RAB11FIP1 SPEN AKAP1 CEP164 RSRC1	1.36e-08	1497	93	19	31527615
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	SETDB1 ZEB1 MRTFB KMT2B GTF3C2 UBR5 BAG3 APC RREB1 CHAMP1 AKAP1	1.67e-08	418	93	11	34709266
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NIFK NCOA6 PNKP ZC3H11A KMT2B GTF3C2 NFIA MDC1 GATA2 FNBP4 MKI67 RREB1 SRRM2 CHAMP1 SPEN RSRC1 CREB3L2	5.39e-08	1294	93	17	30804502
Pubmed	Functional proteomics mapping of a human signaling pathway.	SETDB1 NCOA6 PNKP MRTFB KMT2B ANK3 AP1G1 UBR5 CDK12 PHACTR3 ASH1L FNBP4	6.19e-08	591	93	12	15231748
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	NIFK NCOA6 ZC3H11A MRTFB CDK12 MDC1 MKI67 CHAMP1 SPEN	7.29e-08	283	93	9	30585729
Pubmed	Human transcription factor protein interaction networks.	NIFK SETDB1 NCOA6 UBE2O ZEB1 KMT2B GTF3C2 NFIA G3BP2 MDC1 GATA2 MKI67 GON4L RREB1 SRRM2 SPEN RSRC1	2.21e-07	1429	93	17	35140242
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA6 ZEB1 KMT2B NFIA ASXL3 MDC1 MKI67 RREB1 SPEN	4.48e-07	351	93	9	38297188
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MON2 SETDB1 UBE2O SYNJ2 FLYWCH2 CDK12 MDC1 APC NUCKS1 RREB1 WNK1 AKAP1	6.16e-07	733	93	12	34672954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MON2 SETDB1 ZC3H11A UBR5 ZFR2 GON4L ANKRD12 SRRM2 SPEN	1.52e-06	407	93	9	12693553
Pubmed	Discovery of tissue-specific exons using comprehensive human exon microarrays.	ANK2 PLEKHA6 WNK1	1.54e-06	9	93	3	17456239
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NCOA6 UBE2O GTF3C2 SYNJ2 CDK12 MDC1 CAPRIN2 FNBP4 CHAMP1 ARAP1	1.59e-06	529	93	10	14621295
Pubmed	Onset of Spinal Cord Astrocyte Precursor Emigration from the Ventricular Zone Involves the Zeb1 Transcription Factor.	ZEB1 NFIA MKI67 APC	1.63e-06	32	93	4	27806288
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	ANK2 ANK3 MKI67	2.19e-06	10	93	3	22159418
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	NCOA6 CUX2 MRTFB UBR5 CDK12 WNK1 ARAP1	2.55e-06	225	93	7	12168954
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	NIFK SETDB1 GTF3C2 UBR5 G3BP2 MDC1 FNBP4 MKI67 APC	2.88e-06	440	93	9	34244565
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	KMT2B ANK2 SYNJ2 SCARF2 G3BP2 MKI67 SPEN PRG4	2.98e-06	329	93	8	17474147
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	SETDB1 ZC3H11A GTF3C2 MDC1 RREB1 SRRM2 CHAMP1 EML3	3.19e-06	332	93	8	32786267
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NCOA6 SYNJ2 KIF26B PI4KB BAG3 APC NHS RAB11FIP1 SRRM2 WNK1 AKAP1 RSRC1	3.26e-06	861	93	12	36931259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MON2 CNNM1 NIFK PTPRD ANK3 BAG3 MKI67 NUCKS1 NHS CCDC115 RAB11FIP1 SRRM2 FAN1	4.43e-06	1049	93	13	27880917
Pubmed	A novel nucleolar protein, NIFK, interacts with the forkhead associated domain of Ki-67 antigen in mitosis.	NIFK MKI67	7.07e-06	2	93	2	11342549
Pubmed	Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol.	ZEB1 RAB11FIP1	7.07e-06	2	93	2	32728068
Pubmed	UBR5 is a novel regulator of WNK1 stability.	UBR5 WNK1	7.07e-06	2	93	2	35442829
Pubmed	Knockdown of BAG3 induces epithelial-mesenchymal transition in thyroid cancer cells through ZEB1 activation.	ZEB1 BAG3	7.07e-06	2	93	2	24577090
Pubmed	Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis.	MKI67 APC	7.07e-06	2	93	2	33658388
Pubmed	Structure of human Ki67 FHA domain and its binding to a phosphoprotein fragment from hNIFK reveal unique recognition sites and new views to the structural basis of FHA domain functions.	NIFK MKI67	7.07e-06	2	93	2	14659764
Pubmed	Ectomesenchymal Chondromyxoid Tumor: A Neoplasm Characterized by Recurrent RREB1-MKL2 Fusions.	MRTFB RREB1	7.07e-06	2	93	2	29912715
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	7.07e-06	2	93	2	11781319
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	7.07e-06	2	93	2	25383926
Pubmed	Sequential phosphorylation and multisite interactions characterize specific target recognition by the FHA domain of Ki67.	NIFK MKI67	7.07e-06	2	93	2	16244663
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZC3H11A UBE2O MRTFB ANK2 FLYWCH2 CDK12 BAG3 MKI67 NUCKS1 WNK1 CHAMP1 AKAP1	7.43e-06	934	93	12	33916271
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MON2 HIVEP3 NCOA6 ZC3H11A KMT2B CDK12 PLEKHO2 NFX1 GATA2 WNK1 SPEN EML3 ARAP1	7.74e-06	1105	93	13	35748872
Pubmed	Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth.	ANK2 ANK3 MKI67	8.23e-06	15	93	3	30562487
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FNBP4 PLEKHA6 SPEN RPH3A FAN1	8.32e-06	102	93	5	10231032
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	UBE2O MRTFB KMT2B CDK12 MDC1 FNBP4 MKI67 NUCKS1 SRRM2	8.87e-06	506	93	9	30890647
Pubmed	Chromatin remodeler Ep400 ensures oligodendrocyte survival and is required for myelination in the vertebrate central nervous system.	NFIA MKI67 APC	1.74e-05	19	93	3	31081019
Pubmed	ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease.	NRBP1 ANK2 G3BP2 WNK1 EML3 RPH3A	1.78e-05	202	93	6	33601422
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOA6 CUX2 MRTFB ANK3 MDC1 WNK1 SPEN ARAP1	2.08e-05	430	93	8	35044719
Pubmed	The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells.	ANK2 ANK3	2.12e-05	3	93	2	15611082
Pubmed	β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.	ZEB1 APC	2.12e-05	3	93	2	22080605
Pubmed	Human ankyrins and their contribution to disease biology: An update.	ANK2 ANK3	2.12e-05	3	93	2	33410423
Pubmed	Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene.	ZEB1 APC	2.12e-05	3	93	2	35015732
Pubmed	Putative tumor suppressor EDD interacts with and up-regulates APC.	UBR5 APC	2.12e-05	3	93	2	18076571
Pubmed	Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.	ANK2 ANK3	2.12e-05	3	93	2	34289389
Pubmed	Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.	APC SPEN	2.12e-05	3	93	2	17234755
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	CNNM1 UBR5 SYNJ2 PLEKHO2 G3BP2 APC BCAS1 PLEKHA6 RAB11FIP1 SLC1A4	2.31e-05	719	93	10	35337019
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	NIFK UBE2O AP1G1 HYPK UBR5 FLYWCH2 G3BP2 MDC1 BAG3 FNBP4 SRRM2 WNK1 CHAMP1 RSRC1	2.34e-05	1415	93	14	28515276
Pubmed	DCC regulates astroglial development essential for telencephalic morphogenesis and corpus callosum formation.	NFIA MKI67 APC	2.38e-05	21	93	3	33871356
Pubmed	A census of human transcription factors: function, expression and evolution.	HIVEP3 CUX2 ZC3H11A ZEB1 NFIA ASH1L NFX1 GATA2 GON4L RREB1 CREB3L2	3.14e-05	908	93	11	19274049
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	UBE2O KMT2B GTF3C2 NFIA MDC1 MKI67 RREB1 CHAMP1 SPEN	3.75e-05	608	93	9	36089195
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NCOA6 MRTFB MDC1 MKI67 SRRM2 CHAMP1 SPEN	3.77e-05	341	93	7	32971831
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NIFK NCOA6 ZC3H11A KMT2B UBR5 FLYWCH2 G3BP2 MKI67 NUCKS1 RREB1 SRRM2 SPEN	3.83e-05	1103	93	12	34189442
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NRBP1 NIFK UBE2O ANK2 ANK3 GTF3C2 UBR5 BAG3 FNBP4 CCDC115 RAB11FIP1 SRRM2 AKAP1 SUCO	4.03e-05	1487	93	14	33957083
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ANK2 G3BP2 APC BCAS1 PLEKHA6 SRRM2 SLC1A4	4.21e-05	347	93	7	17114649
Pubmed	Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin.	ANK3 MKI67	4.23e-05	4	93	2	24821222
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A LRRC37A2	4.23e-05	4	93	2	22419166
Pubmed	Integrative approach for prioritizing cancer genes in sporadic colon cancer.	APC TNFRSF11A	4.23e-05	4	93	2	19672874
Pubmed	TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial-Mesenchymal Transition and Invasiveness.	MKI67 APC	4.23e-05	4	93	2	36077674
Pubmed	Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.	MDC1 MKI67 NUCKS1 CHAMP1	4.29e-05	72	93	4	31248990
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NIFK NCOA6 ZC3H11A CDK12 MDC1 FNBP4 MKI67 RREB1 SRRM2 CHAMP1 SPEN	4.91e-05	954	93	11	36373674
Pubmed	A human MAP kinase interactome.	SETDB1 ANK3 SYNJ2 KIF26B BAG3 APC PLEKHA6 WNK1	4.95e-05	486	93	8	20936779
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	NIFK ZC3H11A MDC1 MKI67 NUCKS1	5.01e-05	148	93	5	32538781
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ANK3 CDK12 ASXL3 MDC1 BAG3 SRRM2 SPEN	5.40e-05	361	93	7	26167880
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	NIFK ZC3H11A UBE2O GTF3C2 AP1G1 G3BP2 MKI67	5.69e-05	364	93	7	24778252
Pubmed	The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing.	MDC1 MKI67 SRRM2	6.43e-05	29	93	3	17577209
Pubmed	Glial ankyrins facilitate paranodal axoglial junction assembly.	ANK2 ANK3	7.04e-05	5	93	2	25362471
Pubmed	Identification of stem cells in small intestine and colon by marker gene Lgr5.	MKI67 APC	7.04e-05	5	93	2	17934449
Pubmed	An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.	ANK2 ANK3	7.04e-05	5	93	2	19109891
Pubmed	CK2-regulated schwannomin-interacting protein IQCJ-SCHIP-1 association with AnkG contributes to the maintenance of the axon initial segment.	ANK2 ANK3	7.04e-05	5	93	2	25950943
Pubmed	MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM.	MRTFB APC	7.04e-05	5	93	2	31690663
Pubmed	Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity.	SETDB1 ASH1L	7.04e-05	5	93	2	22939622
Pubmed	The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.	MKI67 APC	7.04e-05	5	93	2	16204028
Pubmed	Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.	ANK3 TNFRSF11A	7.04e-05	5	93	2	33303745
Pubmed	An anthropoid-specific segmental duplication on human chromosome 1q22.	ASH1L GON4L	7.04e-05	5	93	2	16545939
Pubmed	GGA1 interacts with the adaptor protein AP-1 through a WNSF sequence in its hinge region.	AMPH AP1G1	7.04e-05	5	93	2	14973137
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA6 NFIA CDK12 SPEN	7.49e-05	83	93	4	28794006
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	UBE2O ANK3 NFX1 MKI67 APC NHS	7.77e-05	263	93	6	34702444
Pubmed	Dlx1&2-dependent expression of Zfhx1b (Sip1, Zeb2) regulates the fate switch between cortical and striatal interneurons.	CUX2 ZEB1 MKI67	7.88e-05	31	93	3	23312518
Pubmed	Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.	UBR5 CDK12 MDC1 SRRM2	8.22e-05	85	93	4	16051665
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	NIFK PNKP ZC3H11A GTF3C2 UBR5 CDK12 MDC1 MKI67 NUCKS1 MYO15A CHAMP1	8.45e-05	1014	93	11	32416067
Pubmed	Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination.	MKI67 APC CREB3L2	8.68e-05	32	93	3	26928066
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	NIFK ZC3H11A KMT2B GTF3C2 G3BP2 MDC1 FNBP4 MKI67 SRRM2 RSRC1	9.09e-05	847	93	10	35850772
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	NIFK PNKP GTF3C2 NFIA MDC1 ASH1L MKI67 SRRM2	9.40e-05	533	93	8	30554943
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SETDB1 MRTFB AP1G1 UBR5 NFIA PI4KB ATG12 NFX1 PLEKHA6 RAB11FIP1 WNK1	1.04e-04	1038	93	11	26673895
Pubmed	Histone Deacetylase 3 Governs Perinatal Cerebral Development via Neural Stem and Progenitor Cells.	CUX2 MKI67 BCAS1	1.04e-04	34	93	3	31569049
Pubmed	Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out.	UBR5 FAN1	1.05e-04	6	93	2	32876667
Pubmed	Spatiotemporal Role of Transforming Growth Factor Beta 2 in Developing and Mature Mouse Hindbrain Serotonergic Neurons.	GATA2 MKI67	1.05e-04	6	93	2	31619968
Pubmed	Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.	NCOA6 KMT2B	1.05e-04	6	93	2	17021013
Pubmed	Dynamic expression and nuclear accumulation of beta-catenin during the development of hair follicle-derived structures.	MKI67 APC	1.05e-04	6	93	2	11731231
Pubmed	In vivo assembly of the axon initial segment in motor neurons.	ANK2 ANK3	1.05e-04	6	93	2	23728480
Pubmed	Canonical TGFβ signaling induces collective invasion in colorectal carcinogenesis through a Snail1- and Zeb1-independent partial EMT.	ZEB1 APC	1.05e-04	6	93	2	35075245
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	NRDE2 NIFK ZC3H11A CDK12 ATG12 G3BP2 FNBP4 RAB11FIP1 RSRC1	1.11e-04	701	93	9	30196744
Pubmed	Essential roles of the histone methyltransferase ESET in the epigenetic control of neural progenitor cells during development.	SETDB1 CUX2 MKI67	1.14e-04	35	93	3	22991445
Pubmed	The functional interactome landscape of the human histone deacetylase family.	ZC3H11A UBR5 MKI67 ANKRD12 RREB1 SRRM2	1.30e-04	289	93	6	23752268
Pubmed	Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling.	MDC1 MKI67 CHAMP1	1.35e-04	37	93	3	36835656
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	ZC3H11A UBR5 MKI67 ANKRD12 SPEN	1.40e-04	184	93	5	32908313
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MRTFB ANK3 SYNJ2 PLEKHO2 BAG3 PALM3 NHS PLEKHA6	1.40e-04	565	93	8	25468996
Pubmed	Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala.	ASXL3 MKI67 APC	1.46e-04	38	93	3	38086370
Interaction	NUP43 interactions	NIFK NCOA6 MRTFB KMT2B UBR5 NFIA CDK12 MDC1 ASH1L MKI67 APC GON4L SRRM2 CHAMP1 SPEN	1.67e-07	625	93	15	int:NUP43
Interaction	H2BC8 interactions	NIFK UBE2O ZEB1 KMT2B GTF3C2 NFIA FLYWCH2 MDC1 MKI67 NUCKS1 GON4L RREB1 CHAMP1 SPEN	3.86e-07	576	93	14	int:H2BC8
Interaction	TERF2IP interactions	NCOA6 ZC3H11A ZEB1 KMT2B NFIA CDK12 MDC1 MKI67 NUCKS1 RREB1 SRRM2 CHAMP1 SPEN	1.49e-06	552	93	13	int:TERF2IP
Interaction	XRCC6 interactions	NIFK NCOA6 PNKP ZC3H11A UBE2O ZEB1 MRTFB CDK12 ASXL3 MDC1 NFX1 MKI67 SRRM2 CHAMP1 SPEN ARAP1	4.88e-06	928	93	16	int:XRCC6
Interaction	SNRNP40 interactions	NIFK KMT2B UBR5 NFIA CDK12 ATG12 G3BP2 MDC1 MKI67 GON4L SRRM2 SPEN RSRC1	7.09e-06	637	93	13	int:SNRNP40
Interaction	HMGN2 interactions	MON2 NIFK UBE2O CDK12 ASXL3 MDC1 NUCKS1 WNK1	8.71e-06	222	93	8	int:HMGN2
Interaction	SFN interactions	NRBP1 NCOA6 NFIA SYNJ2 KIF26B PI4KB G3BP2 APC NHS ZC2HC1C RAB11FIP1 SRRM2 WNK1	1.71e-05	692	93	13	int:SFN
Interaction	RCOR1 interactions	MRTFB KMT2B UBR5 BAG3 GATA2 MKI67 APC NUCKS1 RREB1 SPEN AKAP1	1.71e-05	494	93	11	int:RCOR1
Interaction	NOLC1 interactions	NIFK PNKP UBE2O UBR5 CDK12 PI4KB G3BP2 APC RAB11FIP1	1.94e-05	325	93	9	int:NOLC1
Interaction	BAG2 interactions	NCOA6 MRTFB GTF3C2 FLYWCH2 MDC1 BAG3 FNBP4 RREB1 SRRM2 WNK1 SPEN AKAP1	2.86e-05	622	93	12	int:BAG2
Interaction	CBX3 interactions	SETDB1 UBE2O ZEB1 KMT2B CDK12 MDC1 MKI67 NUCKS1 RREB1 SRRM2 CHAMP1 SPEN	4.13e-05	646	93	12	int:CBX3
Interaction	ZNF106 interactions	NIFK MDC1 MKI67 APC WNK1	4.35e-05	84	93	5	int:ZNF106
Interaction	RBBP5 interactions	NIFK NCOA6 KMT2B GATA2 MKI67 NUCKS1 SRRM2 SPEN	5.49e-05	287	93	8	int:RBBP5
Interaction	MEN1 interactions	NIFK NCOA6 ZC3H11A MRTFB KMT2B GTF3C2 UBR5 ATG12 G3BP2 MDC1 FNBP4 MKI67 SRRM2 CHAMP1 SPEN	7.00e-05	1029	93	15	int:MEN1
Interaction	HMG20A interactions	NFIA USHBP1 ATG12 GATA2 NUCKS1 GON4L RREB1	1.37e-04	244	93	7	int:HMG20A
Interaction	PTP4A1 interactions	CNNM1 NIFK UBE2O MKI67 CREB3L2	1.38e-04	107	93	5	int:PTP4A1
Interaction	YAP1 interactions	NCOA6 ZC3H11A UBE2O ZEB1 MRTFB KMT2B ANK3 GTF3C2 CDK12 MDC1 BAG3 FNBP4 SRRM2 CHAMP1 SPEN	1.40e-04	1095	93	15	int:YAP1
Interaction	PRP4K interactions	NIFK ZC3H11A UBR5 CDK12 NUCKS1 SRRM2 SPEN FAN1	1.42e-04	329	93	8	int:PRP4K
Interaction	RNPS1 interactions	NRDE2 ZC3H11A UBE2O GTF3C2 UBR5 CDK12 MKI67 SRRM2 CEP164	1.53e-04	425	93	9	int:RNPS1
Cytoband	5q21-q22	ATG12 APC	2.43e-05	4	93	2	5q21-q22
Cytoband	1q32.1	ZC3H11A NUCKS1 PLEKHA6	1.41e-03	108	93	3	1q32.1
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETDB1 KMT2B ASH1L	1.57e-04	34	56	3	487
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	PHACTR3 MKI67 APC WNK1 AKAP1	2.40e-04	181	56	5	694
GeneFamily	Synaptotagmin like tandem C2 proteins	SYTL1 RPH3A	4.17e-04	10	56	2	822
GeneFamily	PHD finger proteins	KMT2B ASH1L NFX1	2.73e-03	90	56	3	88
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	SSC5D SCARF2	3.15e-03	27	56	2	1253
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	CMYA5 AKAP1	3.63e-03	29	56	2	396
GeneFamily	Zinc fingers CCCH-type	ZC3H11A ZC3H11B	5.25e-03	35	56	2	73
GeneFamily	Tudor domain containing	SETDB1 AKAP1	5.85e-03	37	56	2	780
GeneFamily	Ankyrin repeat domain containing	ANK2 ANK3 ANKRD12 ARAP1	6.67e-03	242	56	4	403
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	HIVEP3 AMPH ANK2 ANK3 ASXL3 PHACTR3 GATA2 APC PLEKHA6 AKAP1 RPH3A	8.03e-07	465	93	11	M39066
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	PTPRD ANK2 ANK3 NFIA ASH1L NHS PLEKHA6 SRRM2	1.24e-06	221	93	8	M39222
Coexpression	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	ZC3H11A RSAD2 GTF3C2 PI4KB ATG12 G3BP2 ANKRD12	7.38e-06	200	93	7	M8559
Coexpression	GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP	ZC3H11A KMT2B ATG12 WNK1 EML3 CEP164	3.37e-05	171	93	6	M7105
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	CNNM1 ZEB1 KMT2B NBEAL1 NUCKS1 WNK1	4.48e-05	180	93	6	M8239
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	ZC3H11A ZEB1 ANK3 CDK12 FNBP4 NUCKS1 GON4L ANKRD12	4.58e-05	363	93	8	M41103
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	NCOA6 PTPRD HYPK NFIA GATA2 NUCKS1 GON4L WNK1 RSRC1	5.65e-05	484	93	9	MM999
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	HIVEP3 AMPH ANK2 ANK3 PHACTR3 ANKRD12 PLEKHA6 AKAP1 SLC1A4	7.94e-05	506	93	9	M39067
Coexpression	GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN	NRBP1 NCOA6 PLEKHO2 G3BP2 CHAMP1 ARAP1	8.04e-05	200	93	6	M5859
Coexpression	GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP	NRBP1 UBR5 BAG3 FNBP4 APC SYTL1	8.04e-05	200	93	6	M3419
Coexpression	GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN	AP1G1 SYNJ2 G3BP2 FNBP4 TNFRSF11A SPEN	8.04e-05	200	93	6	M8781
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP	NRBP1 NRDE2 NFIA PLEKHO2 FHDC1 WNK1	8.04e-05	200	93	6	M3840
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL	SSC5D ZEB1 KIF26B FHDC1 AKAP1	8.14e-05	124	93	5	M45673
Coexpression	HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS	ANK2 ANK3 ZFR2 ASXL3 PHACTR3	1.26e-04	136	93	5	MM407
Coexpression	MURARO_PANCREAS_BETA_CELL	G3BP2 BAG3 ASH1L APC NUCKS1 ANKRD12 TNFRSF11A PLEKHA6 RAB11FIP1 SUCO SLC1A4 CREB3L2	1.29e-04	946	93	12	M39169
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	MON2 MRTFB NFIA SYNJ2 PI4KB LRRC37A2 GON4L FHDC1 TNFRSF11A SRRM2 AKAP1	1.35e-04	807	93	11	M16651
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	NCOA6 RSAD2 KMT2B PLEKHO2 BAG3 FNBP4 GON4L ANKRD12 RAB11FIP1 MMP10 SLC1A4	1.59e-04	822	93	11	M6782
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000	RSAD2 ANK3 GTF3C2 CDK12 APC GON4L SUCO CEP164	1.52e-05	261	90	8	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	CUX2 ANK2 ANK3 NFIA FLYWCH2 KIF26B CDK12 ASXL3 GATA2 APC WNK1 SLC1A4 PARM1	3.97e-05	818	90	13	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HIVEP3 AMPH PTPRD SCARF2 PHACTR3 PLEKHA6 SLC1A4 ARAP1	7.10e-09	192	93	8	0afb9dbe468e0be442c326e11c5fc0f699b32f23
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HIVEP3 AMPH PTPRD SCARF2 PHACTR3 SLC1A4 ARAP1	4.82e-08	161	93	7	b19f82dd98a3064581793711bb70373f18abecd9
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HIVEP3 AMPH PTPRD SCARF2 PHACTR3 SLC1A4 ARAP1	1.55e-07	191	93	7	a05e9a7eb137d804570dd7d8905975d735738767
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD ZAN KIF26B ASXL3 PHACTR3 MYO15A	2.45e-06	184	93	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD ZAN KIF26B ASXL3 PHACTR3 MYO15A	2.45e-06	184	93	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD ZAN KIF26B ASXL3 PHACTR3 MYO15A	2.45e-06	184	93	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	MON2 AP1G1 ASH1L ANKRD12 SPEN SUCO	2.77e-06	188	93	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 AMPH PTPRD PHACTR3 PLEKHA6 ARAP1	3.22e-06	193	93	6	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 AMPH PTPRD PHACTR3 PLEKHA6 ARAP1	3.42e-06	195	93	6	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	PND10-Mesenchymal-Mesenchymal_structural\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 AMPH PTPRD PHACTR3 PLEKHA6 ARAP1	3.42e-06	195	93	6	11d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 AMPH PTPRD PHACTR3 PLEKHA6 ARAP1	3.42e-06	195	93	6	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 AMPH PTPRD PHACTR3 PLEKHA6 ARAP1	3.42e-06	195	93	6	10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	NRDE2 ZEB1 CAPRIN2 ANKRD12 SRRM2 CEP164	3.63e-06	197	93	6	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Influenza-Influenza_Severe-Others-RBC\|Influenza_Severe / Disease, condition lineage and cell class	UBE2O RSAD2 FHDC1 WNK1 SUCO TNXB	3.84e-06	199	93	6	da0fec0a492bc3827d9066d2590bcd466cd45564
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIVEP3 CNNM1 SYNJ2 NHS FAN1	2.03e-05	158	93	5	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CCNJL ANK3 PALM3 AKAP1 PARM1	2.09e-05	159	93	5	e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell	Mild-Lymphoid-NK-innate_T\|Mild / Condition, Lineage, Cell class and cell subclass	KMT2B ANK3 ZC3H11B NHS SYTL1	2.29e-05	162	93	5	bd218e41b2eadc3bba4c7ac3e34a014f6ad8b1bf
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	LRRC37A ANK3 ASH1L FNBP4 ANKRD12	2.29e-05	162	93	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	Adult-Epithelial-lung_goblet_cell-D175\|Adult / Lineage, Cell type, age group and donor	KIF26B KCNV2 NHS BCAS1 PLEKHA6	2.43e-05	164	93	5	6e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCell	droplet-Mammary_Gland-nan-3m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSAD2 USHBP1 PLEKHO2 GATA2 FAN1	3.14e-05	173	93	5	fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSAD2 NBEAL1 CDK12 ASH1L SRRM2	3.59e-05	178	93	5	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	droplet-Spleen-nan-21m-Hematologic-erythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBE2O RSAD2 ZFR2 FHDC1	3.65e-05	89	93	4	e7d9498a1a3aa974fdd68b394c3eaff8e35c9727
ToppCell	COPD-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	HIVEP3 CUX2 ZEB1 SLC1A4 CREB3L2	3.69e-05	179	93	5	29b058c5e33fda9f0d738c074bdb67ff16b9b6d5
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIVEP3 PTPRD PHACTR3 PLEKHA6 TNXB	3.79e-05	180	93	5	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	ANK3 AP1G1 UBR5 ASH1L ANKRD12	3.89e-05	181	93	5	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	Hippocampus-Neuronal-Inhibitory\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CUX2 UBR5 APC NHS RPH3A	3.99e-05	182	93	5	b54ae650c04dfd0759c5f5e752b9bf684dd36516
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SSC5D LRRC37A ANK2 PRG4 TNXB	4.10e-05	183	93	5	06a68fa2be36448064f4668be24a5b85ad85c6e8
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SSC5D ZEB1 KIF26B NHS FHDC1	4.10e-05	183	93	5	e84539978ab4de42e19186aed00f24bb50cbc21f
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	CCNJL PTPRD ANK3 NFIA PARM1	4.32e-05	185	93	5	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CCNJL PTPRD ANK3 KCNV2 PARM1	4.43e-05	186	93	5	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRD ANK3 NFIA KIF26B NHS	4.43e-05	186	93	5	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	NBEAL1 CDK12 APC ANKRD12 CHAMP1	4.43e-05	186	93	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBEAL1 CDK12 ASH1L ANKRD12 SRRM2	4.54e-05	187	93	5	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SSC5D ZEB1 KIF26B NHS FHDC1	4.66e-05	188	93	5	3004e961d214919e08c7cd5f10c3de5cf85b35a3
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SSC5D ZEB1 KIF26B NHS FHDC1	4.78e-05	189	93	5	f75cebd4c3e54e297557449ba67ccc8d1a2a14f5
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SSC5D ZEB1 KIF26B NHS AKAP1	4.78e-05	189	93	5	0abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNJL PTX4 GATA2 RAB11FIP1 CREB3L2	4.78e-05	189	93	5	fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIVEP3 PTPRD ANK2 KIF26B NHS	4.90e-05	190	93	5	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRD ANK3 NFIA NHS PLEKHA6	5.02e-05	191	93	5	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRD ANK3 NFIA NHS PLEKHA6	5.02e-05	191	93	5	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	MON2 UBR5 SYNJ2 SRRM2 WNK1	5.15e-05	192	93	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 AMPH PTPRD SCARF2 PLEKHA6	5.15e-05	192	93	5	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD SCARF2 PRG4 TNXB CREB3L2	5.15e-05	192	93	5	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	CAPRIN2 ASH1L MKI67 ANKRD12 SRRM2	5.15e-05	192	93	5	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MON2 ANK3 AP1G1 ASH1L ANKRD12	5.15e-05	192	93	5	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HIVEP3 PTPRD SCARF2 SLC1A4 ARAP1	5.15e-05	192	93	5	2802fae55683345ff94a1ecf73b6fbee4f17481e
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 AMPH PTPRD SCARF2 PLEKHA6	5.15e-05	192	93	5	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ANK2 TNFRSF11A CMYA5 RAB11FIP1 TNXB	5.15e-05	192	93	5	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRD ANK3 ASH1L NHS DNAAF9	5.15e-05	192	93	5	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRD ANK2 KIF26B PHACTR3 NHS	5.15e-05	192	93	5	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	UBE2O RSAD2 FHDC1 WNK1 TNXB	5.28e-05	193	93	5	305e15ee467826ee08b2617c69f250ad39c11b19
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SSC5D ZEB1 KIF26B NHS AKAP1	5.28e-05	193	93	5	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 PTPRD PHACTR3 PLEKHA6 ARAP1	5.28e-05	193	93	5	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRD ANK2 ASXL3 PHACTR3 NHS	5.28e-05	193	93	5	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	MON2 UBR5 SYNJ2 SRRM2 WNK1	5.28e-05	193	93	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	severe_influenza-RBC\|severe_influenza / disease group, cell group and cell class (v2)	UBE2O FHDC1 WNK1 SUCO TNXB	5.28e-05	193	93	5	ffb0b3c2cce13b6891157f0fede2600f3938670e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22\|World / Primary Cells by Cluster	CUX2 PTPRD ANK2 KIF26B FHDC1	5.28e-05	193	93	5	3b927d4b8ecb21a408424ef91a23746c21741f49
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	UBE2O RSAD2 FHDC1 WNK1 TNXB	5.28e-05	193	93	5	dd376664906caccc9c2065f8e7a364509e18a5cc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPRD ANK3 NHS PLEKHA6 CMYA5	5.41e-05	194	93	5	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NRDE2 UBR5 SYNJ2 MKI67 FAN1	5.41e-05	194	93	5	8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CCNJL PTPRD ANK3 FHDC1 PARM1	5.41e-05	194	93	5	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRD ANK2 KIF26B ASXL3 NHS	5.41e-05	194	93	5	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 AMPH PTPRD SCARF2 PLEKHA6	5.54e-05	195	93	5	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIVEP3 AMPH PTPRD SCARF2 PLEKHA6	5.54e-05	195	93	5	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD ASH1L CMYA5 SRRM2 CREB3L2	5.54e-05	195	93	5	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTX4 KIF26B GATA2 RAB11FIP1 PARM1	5.68e-05	196	93	5	7d5eaed189aa6116f3799be010139fb675ec65e0
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HIVEP3 PTPRD SCARF2 NUCKS1 ARAP1	5.68e-05	196	93	5	028a06ed92f1c058dcbeacd335625bf529e87a7b
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSC5D PTX4 PTPRD SCARF2 PRG4	5.68e-05	196	93	5	fcb275746bf51269ed8ba4cf93edb054a45f1ccd
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PTPRD ANK2 NHS PLEKHA6 TNXB	5.82e-05	197	93	5	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZEB1 ANK3 KIF26B BAG3 MYO15A	5.82e-05	197	93	5	2a90422ba400b951517603a916f34221056d0f3d
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTX4 PTPRD SCARF2 PRG4 CREB3L2	5.82e-05	197	93	5	cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCell	3'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AP1G1 BAG3 ANKRD12 SRRM2 PARM1	5.96e-05	198	93	5	7ad7726fc405806b1d7824f58548073ea5e0c70b
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AP1G1 BAG3 ANKRD12 SRRM2 PARM1	5.96e-05	198	93	5	1fbec311f2c987ca90a023a5989128c05aa12d5c
ToppCell	3'-Adult-Distal_Rectal-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AP1G1 BAG3 ANKRD12 SRRM2 PARM1	5.96e-05	198	93	5	ceede961ad9af6a3159db7efaa5087bf38aafc2d
ToppCell	3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AP1G1 BAG3 ANKRD12 SRRM2 PARM1	5.96e-05	198	93	5	4f26a60e99f42343e5af7221723e108a1a1b7827
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	PTPRD ANK2 ANK3 APC ANKRD12	6.10e-05	199	93	5	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	Neuron\|World / Primary Cells by Cluster	PTPRD ANK2 ANK3 ASXL3 ANKRD12	6.10e-05	199	93	5	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	PTPRD ANK2 ANK3 ASXL3 ANKRD12	6.10e-05	199	93	5	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	PTPRD ANK2 ANK3 APC ANKRD12	6.10e-05	199	93	5	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SSC5D ANK2 ANK3 PRG4 TNXB	6.25e-05	200	93	5	747c61d4e0b746278ae1f45ca4cd556c6961c76a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ZEB1 MRTFB UBR5 USHBP1 ASH1L	6.25e-05	200	93	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	NFIA SYNJ2 NHS BCAS1 CMYA5	6.25e-05	200	93	5	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	COVID-19-COVID-19_Severe-Others-RBC\|COVID-19_Severe / Disease, condition lineage and cell class	UBE2O RSAD2 FHDC1 WNK1 TNXB	6.25e-05	200	93	5	308f74e7e13ecc6d133c219c42cc8895a96644c8
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRD ANK2 SCARF2 PRG4 TNXB	6.25e-05	200	93	5	8c62f05c6042f24287a73fbdf80ff4a56f7ff403
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	HIVEP3 ANK3 ASXL3 ANKRD12 RPH3A	6.25e-05	200	93	5	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SSC5D ANK2 ANK3 PRG4 TNXB	6.25e-05	200	93	5	de1d193f773f4e2927baa6fc38d29754b015c6e6
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	SSC5D ANK2 SCARF2 PRG4 TNXB	6.25e-05	200	93	5	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	HIVEP3 CUX2 ASXL3 ANKRD12 RPH3A	6.25e-05	200	93	5	306926cb7a847871641f02e03d52dc56fd55711c
ToppCell	P07-Hematopoietic-Erythroid\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	UBE2O RSAD2 FHDC1 PRG4	1.06e-04	117	93	4	1820396bd590020a83fac3416d559e32f41eab61
ToppCell	P07-Hematopoietic-Erythroid-enucleate_erythrocyte\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	UBE2O RSAD2 FHDC1 PRG4	1.06e-04	117	93	4	43c7257788fe3d53d663365d1754aee6ad88bbc5
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	ASH1L SPEN EML3 ARAP1	1.25e-04	122	93	4	1ed865f0ecfe304fb86313ff51c04e9052357270
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma-4\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	USHBP1 PRG4 TNXB ARAP1	1.29e-04	123	93	4	12b87d06e62f142e18424aae5c87454e78e713f0
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SSC5D CUX2 CMYA5 TNXB	1.55e-04	129	93	4	5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	ZC3H11A ASH1L APC ANKRD12	2.00e-04	138	93	4	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	RSAD2 USHBP1 GATA2 RAB11FIP1	2.36e-04	144	93	4	1c118b22c2ff3a526a5207d6c9d772636ee065fd
ToppCell	E16.5-samps-Mesenchymal-Pericyte\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CNNM1 AMPH ZC2HC1C PARM1	2.62e-04	148	93	4	e697a7fb037873c9b11703d1bf836a69fc276e23
ToppCell	E16.5-samps-Mesenchymal-Pericyte-pericyte_A\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CNNM1 AMPH ZC2HC1C PARM1	2.62e-04	148	93	4	c87fe2373418ec0cfe37279003d1c4df4c0d0aac
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	RSAD2 USHBP1 GATA2 RAB11FIP1	2.68e-04	149	93	4	d9c47f523c75ddcd6131e45d2ffc24b970932cae
ToppCell	remission-unassigned\|remission / disease stage, cell group and cell class	ZFR2 GATA2 NUCKS1 TNFRSF11A	3.04e-04	154	93	4	4130769829b838cc8a075c87ff6c187f0f507f8b
ToppCell	368C-Fibroblasts-Fibroblast-H\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	AMPH GTF3C2 PALM3 NHS	3.04e-04	154	93	4	f29316d4b4dcdb23bd427d78068e65a9802f7f07
Drug	deoxynivalenol	SETDB1 ZC3H11A ZEB1 PLEKHO2 PI4KB G3BP2 BAG3 MKI67 NUCKS1 PLEKHA6 SRRM2 CHAMP1	5.41e-07	481	92	12	ctd:C007262
Drug	Cefoperazone dihydrate; Up 200; 5.8uM; PC3; HT_HG-U133A	CNNM1 PTPRD SYNJ2 NFX1 GATA2 SLC1A4 EML3 PARM1	1.42e-06	198	92	8	6323_UP
Drug	benz(a)anthracene	CCNJL RSAD2 ANK3 GTF3C2 USHBP1 NBEAL1 KIF26B BAG3 GATA2 FNBP4 MKI67 GON4L ANKRD12 RAB11FIP1 SRRM2 SLC1A4 PARM1	9.55e-06	1251	92	17	ctd:C030935
Drug	Tolazamide [1156-19-0]; Up 200; 12.8uM; PC3; HT_HG-U133A	SETDB1 NFX1 ZC2HC1C BCAS1 MYO15A WNK1 EML3	1.44e-05	195	92	7	4003_UP
Drug	Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	PLEKHO2 G3BP2 ASH1L APC AKAP1 SLC1A4 EML3	1.49e-05	196	92	7	6506_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SYNJ2 PLEKHO2 APC GON4L WNK1 SLC1A4 ARAP1	1.49e-05	196	92	7	2232_DN
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	HIVEP3 CNNM1 KMT2B PLEKHO2 BCAS1 EML3 ARAP1	1.54e-05	197	92	7	6456_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	SETDB1 KMT2B PLEKHO2 ATG12 MKI67 SRRM2 RSRC1	1.54e-05	197	92	7	2070_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	KMT2B SYNJ2 PLEKHO2 APC GON4L SRRM2 WNK1	1.59e-05	198	92	7	4592_DN
Drug	Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A	ANK3 PLEKHO2 APC GON4L PLEKHA6 RSRC1 ARAP1	1.64e-05	199	92	7	1500_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	ZEB1 PLEKHO2 ASH1L WNK1 SLC1A4 CEP164 ARAP1	1.64e-05	199	92	7	3543_DN
Drug	Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	CCNJL SYNJ2 GON4L PLEKHA6 RAB11FIP1 SLC1A4 ARAP1	1.69e-05	200	92	7	7031_UP
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A	KMT2B SYNJ2 ASH1L NFX1 APC SRRM2 PARM1	1.69e-05	200	92	7	4525_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	MON2 CNNM1 KMT2B APC GON4L ZC2HC1C SLC1A4	1.69e-05	200	92	7	6679_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	ZEB1 ANK3 SRRM2 SPEN AKAP1 RSRC1	8.85e-05	179	92	6	4585_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	UBE2O ZEB1 MRTFB APC ANKRD12 RREB1	9.12e-05	180	92	6	4541_DN
Drug	Coal Tar	CCNJL PNKP NBEAL1 KIF26B GATA2 MKI67 ANKRD12 BCAS1	1.06e-04	360	92	8	ctd:D003033
Drug	Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A	CDK12 PLEKHO2 G3BP2 ASH1L MKI67 ANKRD12	1.19e-04	189	92	6	2041_DN
Drug	Methotrexate [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A	PLEKHO2 G3BP2 MKI67 APC WNK1 EML3	1.23e-04	190	92	6	6318_DN
Drug	Clidinium bromide [3485-62-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CNNM1 SYNJ2 NFX1 APC EML3 CEP164	1.26e-04	191	92	6	6837_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	SYNJ2 GON4L WNK1 SPEN EML3 RSRC1	1.26e-04	191	92	6	4269_DN
Drug	0175029-0000 [211245-78-2]; Up 200; 1uM; PC3; HT_HG-U133A	CNNM1 GTF3C2 PLEKHO2 APC RREB1 EML3	1.30e-04	192	92	6	7392_UP
Drug	Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; PC3; HT_HG-U133A	CCNJL HIVEP3 KMT2B SRRM2 AKAP1 EML3	1.34e-04	193	92	6	1816_UP
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ANK3 CAPRIN2 ASH1L NFX1 APC SRRM2	1.38e-04	194	92	6	4952_DN
Drug	Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A	HIVEP3 SYNJ2 NFX1 BCAS1 PLEKHA6 SLC1A4	1.41e-04	195	92	6	6247_UP
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; PC3; HT_HG-U133A	SETDB1 GATA2 APC WNK1 SLC1A4 ARAP1	1.41e-04	195	92	6	7288_UP
Drug	Tenoxicam [59804-37-4]; Up 200; 11.8uM; HL60; HT_HG-U133A	ZEB1 ANK3 KIF26B APC SRRM2 CEP164	1.41e-04	195	92	6	2501_UP
Drug	Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A	HIVEP3 PLEKHO2 BCAS1 SRRM2 WNK1 ARAP1	1.41e-04	195	92	6	3358_DN
Drug	Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A	GATA2 MKI67 GON4L WNK1 EML3 ARAP1	1.45e-04	196	92	6	5724_DN
Drug	Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	PLEKHO2 NFX1 APC RAB11FIP1 WNK1 FAN1	1.45e-04	196	92	6	2874_DN
Drug	Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	ZEB1 PLEKHO2 APC GON4L EML3 PARM1	1.45e-04	196	92	6	2103_DN
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A	KMT2B SYNJ2 SRRM2 WNK1 SPEN EML3	1.45e-04	196	92	6	5288_UP
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	SETDB1 SYNJ2 ASH1L APC BCAS1 SLC1A4	1.45e-04	196	92	6	7228_DN
Drug	Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SYNJ2 PLEKHO2 NFX1 GON4L WNK1 FAN1	1.45e-04	196	92	6	2755_DN
Drug	Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A	MRTFB UBR5 PI4KB CAPRIN2 RREB1 AKAP1	1.45e-04	196	92	6	7139_DN
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A	HIVEP3 KMT2B APC WNK1 SLC1A4 EML3	1.45e-04	196	92	6	3762_DN
Drug	alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A	SYNJ2 PI4KB NFX1 APC EML3 ARAP1	1.50e-04	197	92	6	1151_DN
Drug	Bisoprolol fumarate; Up 200; 9uM; HL60; HT_HG-U133A	MON2 ZEB1 MRTFB GTF3C2 G3BP2 ANKRD12	1.50e-04	197	92	6	1287_UP
Drug	Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A	HIVEP3 NRDE2 PTPRD PLEKHO2 ZC2HC1C RPH3A	1.50e-04	197	92	6	3390_UP
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; PC3; HT_HG-U133A	CCNJL CNNM1 ZEB1 SYNJ2 GATA2 APC	1.50e-04	197	92	6	2126_DN
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A	SETDB1 ZEB1 PI4KB NFX1 APC EML3	1.50e-04	197	92	6	3769_DN
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A	SYNJ2 PLEKHO2 NFX1 GON4L WNK1 SLC1A4	1.50e-04	197	92	6	3364_DN
Drug	Perphenazine [58-39-9]; Down 200; 10uM; HL60; HG-U133A	GTF3C2 SYNJ2 FNBP4 ANKRD12 AKAP1 CEP164	1.50e-04	197	92	6	2040_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; PC3; HT_HG-U133A	NFX1 APC PLEKHA6 SRRM2 WNK1 ARAP1	1.54e-04	198	92	6	3711_DN
Drug	Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A	MON2 ZEB1 APC WNK1 SLC1A4 CEP164	1.54e-04	198	92	6	5446_UP
Drug	Iocetamic acid [16034-77-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A	HIVEP3 PLEKHO2 ANKRD12 SRRM2 WNK1 SLC1A4	1.54e-04	198	92	6	3361_DN
Drug	Caffeic acid [3331-39-5]; Down 200; 22.2uM; MCF7; HT_HG-U133A	KMT2B ANK3 GTF3C2 SYNJ2 SRRM2 EML3	1.54e-04	198	92	6	5352_DN
Drug	sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A	ANK2 SYNJ2 MYO15A AKAP1 SUCO CREB3L2	1.58e-04	199	92	6	309_DN
Drug	Aminophylline [317-34-0]; Up 200; 9.6uM; PC3; HT_HG-U133A	AMPH KMT2B NFX1 APC EML3 ARAP1	1.58e-04	199	92	6	6295_UP
Drug	Anabasine [494-52-0]; Down 200; 24.6uM; MCF7; HT_HG-U133A	PLEKHO2 CAPRIN2 NFX1 GON4L PLEKHA6 CEP164	1.58e-04	199	92	6	6074_DN
Drug	Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A	KMT2B PI4KB NFX1 SLC1A4 EML3 CEP164	1.58e-04	199	92	6	5286_UP
Drug	Methantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A	MON2 SYNJ2 NFX1 ZC2HC1C BCAS1 WNK1	1.58e-04	199	92	6	3560_UP
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A	MON2 ZEB1 PTPRD NFX1 WNK1 CEP164	1.58e-04	199	92	6	4775_UP
Drug	Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A	ZEB1 APC ZC2HC1C AKAP1 RPH3A ARAP1	1.62e-04	200	92	6	4759_UP
Drug	Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A	HIVEP3 PLEKHO2 ZC2HC1C TNFRSF11A PLEKHA6 SRRM2	1.62e-04	200	92	6	6676_DN
Drug	PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A	HIVEP3 CNNM1 KMT2B SYNJ2 SLC1A4 CEP164	1.62e-04	200	92	6	6907_DN
Drug	chrysene	CCNJL ANK3 UBR5 NBEAL1 KIF26B GATA2 MKI67 ANKRD12 RAB11FIP1 SRRM2 TNXB PARM1	1.99e-04	871	92	12	ctd:C031180
Disease	Malignant neoplasm of breast	NCOA6 ZC3H11A ZEB1 LRRC37A PTPRD ANK2 SYNJ2 SCARF2 G3BP2 LRRC37A2 MKI67 NHS MMP10 WNK1 SPEN	9.75e-07	1074	91	15	C0006142
Disease	testosterone measurement	NRDE2 NCOA6 CUX2 ZAN ANK2 ANK3 GTF3C2 NFIA FNBP4 PALM3 ZC3H11B BCAS1 RREB1 MYO15A CHAMP1 ARAP1	1.65e-06	1275	91	16	EFO_0004908
Disease	venous thromboembolism	NCOA6 RSAD2 ANK2 ANK3 KIF26B FNBP4 BCAS1 SRRM2	9.01e-05	460	91	8	EFO_0004286
Disease	chloride measurement	CUX2 BCAS1 RPH3A	9.78e-05	29	91	3	EFO_0009284
Disease	glucose measurement	NRBP1 CUX2 LRRC37A ZAN NFX1 RREB1 ARAP1	1.78e-04	380	91	7	EFO_0004468
Disease	Neurodevelopmental Disorders	HIVEP3 ANK2 ASXL3 ASH1L	2.00e-04	93	91	4	C1535926
Disease	renin measurement	NBEAL1 PLEKHA6	2.60e-04	8	91	2	EFO_0010616
Disease	synaptotagmin-11 measurement	GON4L RREB1	3.34e-04	9	91	2	EFO_0802108
Disease	pulse pressure measurement	HIVEP3 CUX2 PTPRD ANK2 NBEAL1 PLEKHO2 GATA2 ZC3H11B ZC2HC1C RREB1 RPH3A CEP164 CREB3L2	3.37e-04	1392	91	13	EFO_0005763
Disease	total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement	NUCKS1 ZC3H11B RPH3A	4.72e-04	49	91	3	EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
Disease	Intellectual Disability	CUX2 NFIA ASH1L APC GON4L CHAMP1 SLC1A4	4.73e-04	447	91	7	C3714756
Disease	forced expiratory volume	SSC5D NCOA6 SCARF2 CDK12 PLEKHO2 NUCKS1 TNXB EML3 RSRC1	7.41e-04	789	91	9	EFO_0004314
Disease	third ventricle volume measurement	PTPRD ANK3	9.62e-04	15	91	2	EFO_0010335
Disease	stomach cancer (is_marker_for)	UBR5 CDK12 MKI67 TNFRSF11A	9.93e-04	142	91	4	DOID:10534 (is_marker_for)
Disease	alkaline phosphatase measurement	HIVEP3 CUX2 SYNJ2 ATG12 NUCKS1 TNFRSF11A BCAS1 RREB1 RPH3A CREB3L2	1.15e-03	1015	91	10	EFO_0004533
Disease	Mammary Carcinoma, Human	ZC3H11A ZEB1 LRRC37A PTPRD SYNJ2 LRRC37A2 MKI67	1.21e-03	525	91	7	C4704874
Disease	Mammary Neoplasms, Human	ZC3H11A ZEB1 LRRC37A PTPRD SYNJ2 LRRC37A2 MKI67	1.21e-03	525	91	7	C1257931
Disease	Mammary Neoplasms	ZC3H11A ZEB1 LRRC37A PTPRD SYNJ2 LRRC37A2 MKI67	1.24e-03	527	91	7	C1458155
Disease	Benign neoplasm of stomach	UBR5 APC	1.24e-03	17	91	2	C0153943
Disease	body fat percentage, type 2 diabetes mellitus	ZC3H11B ARAP1	1.24e-03	17	91	2	EFO_0007800, MONDO_0005148
Disease	Neoplasm of uncertain or unknown behavior of stomach	UBR5 APC	1.24e-03	17	91	2	C0496905
Disease	Carcinoma in situ of stomach	UBR5 APC	1.24e-03	17	91	2	C0154060
Disease	level of Phosphatidylcholine (14:0_18:2) in blood serum	NRBP1 GTF3C2	1.24e-03	17	91	2	OBA_2045063
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B SRRM2	1.24e-03	17	91	2	DOID:0060307 (is_implicated_in)
Disease	nephrotic syndrome	PTPRD TNXB PARM1	1.39e-03	71	91	3	EFO_0004255
Disease	Breast Carcinoma	ZC3H11A ZEB1 LRRC37A PTPRD SYNJ2 LRRC37A2 MKI67	1.39e-03	538	91	7	C0678222
Disease	reticulocyte count	NCOA6 UBE2O ASH1L PROCA1 PALM3 ZC3H11B DNAAF9 FHDC1 RREB1 RPH3A	1.43e-03	1045	91	10	EFO_0007986
Disease	vital capacity	NCOA6 PTPRD NFIA CDK12 CAPRIN2 NUCKS1 RREB1 CHAMP1 TNXB EML3 RSRC1	1.47e-03	1236	91	11	EFO_0004312
Disease	alcohol consumption measurement	NRBP1 CUX2 AP1G1 NFIA CDK12 FNBP4 NUCKS1 ZC3H11B MYO15A RPH3A RSRC1	1.53e-03	1242	91	11	EFO_0007878
Disease	Stomach Carcinoma	UBR5 APC	1.90e-03	21	91	2	C0699791
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	HIVEP3 KMT2B TNFRSF11A ARAP1	1.93e-03	170	91	4	EFO_0000685, EFO_0007791, EFO_0007837
Disease	breast cancer, COVID-19	CUX2 GON4L	2.09e-03	22	91	2	MONDO_0007254, MONDO_0100096
Disease	QRS duration	PTPRD UBR5 NFIA BAG3 NUCKS1	2.33e-03	298	91	5	EFO_0005055
Disease	white matter hyperintensity measurement	PTPRD ZAN ANK2 NBEAL1 GON4L	2.47e-03	302	91	5	EFO_0005665
Disease	Anhedonia	SETDB1 ANK3	2.48e-03	24	91	2	C0178417
Disease	gastric carcinoma	CUX2 ASH1L GON4L	2.66e-03	89	91	3	EFO_0000178
Disease	osteonecrosis	HIVEP3 PTPRD	2.69e-03	25	91	2	EFO_0004259
Disease	blood urea nitrogen measurement	CUX2 CDK12 GON4L BCAS1 PLEKHA6 RREB1	2.78e-03	452	91	6	EFO_0004741
Disease	cortical surface area measurement	MON2 ZAN ANK3 NFIA NBEAL1 KIF26B MDC1 APC DNAAF9 RREB1 TNXB	2.84e-03	1345	91	11	EFO_0010736
Disease	Hereditary Nonpolyposis Colorectal Neoplasms	APC FAN1	2.91e-03	26	91	2	C0009405

Protein segments in the cluster

Peptide	Gene	Start	Entry
PSPEGSSVDKPTPQE	USHBP1	406	Q8N6Y0
PPSVTEPPEKELSTV	AKAP1	71	Q92667
IPSPSETPAKPSEPE	ASH1L	1951	Q9NR48
KETETSEKETPPPLP	CDK12	516	Q9NYV4
GPTKTPEPESSEAPQ	CCDC115	106	Q96NT0
PPTPPQVAETTGKFE	CCNJL	131	Q8IV13
LTVPGDTSPSPKPEV	ANKRD12	1336	Q6UB98
SPPPSPTEPEKSSQE	CUX2	986	O14529
GLTDVSPETTTPEPP	ATG12	21	O94817
KEGPPNLEVSSTPET	ASXL3	1136	Q9C0F0
GPTSETPELATEQKP	AMPH	576	P49418
LDTPEKTVDSQGPTP	NIFK	221	Q9BYG3
PDSLPSTPSPVESTK	NBEAL1	1391	Q6ZS30
LPVPDTKPPTTSTEG	NFIA	451	Q12857
PSEDPTSKDPQSPEG	PALM3	61	A6NDB9
PSSPSKTPEEVSTPA	ANK2	3791	Q01484
TNGETEPAPLETKPP	AP1G1	601	O43747
PASTEEPLVPTKSVP	MMP10	266	P09238
EPESPPEKKTSTSPP	NUCKS1	211	Q9H1E3
ESPKEEPKTPSVPSV	FHDC1	1011	Q9C0D6
SSVKTPEPVVPTAPE	MDC1	1276	Q14676
KPSPTTEETSTQPPD	LRRC37A2	736	A6NM11
KPSPTTEETSTQPPD	LRRC37A	736	A6NMS7
EKPPAPEAQPTSVGT	MYO15A	2491	Q9UKN7
EPEAPTATPKAGPTL	KIF26B	1406	Q2KJY2
ASQEPSPKPGTEVIP	FLYWCH2	16	Q96CP2
PSEPKVSESPSPVTT	MRTFB	201	Q9ULH7
SKTEPPSSEPISFIP	NRDE2	241	Q9H7Z3
TTPKPEDAGPESTKP	NFX1	196	Q12986
PPEDSPTVAPKSTTF	KMT2B	506	Q9UMN6
SPPPESVDTPTSTKQ	MKI67	1131	P46013
VSPVRDSDKPETPPV	MON2	1176	Q7Z3U7
TAEPVPQEKTPPTTV	PARM1	211	Q6UWI2
PPSVKTPTPEPAEVE	NRBP1	426	Q9UHY1
STELDSKTPTPPAPT	NCOA6	1871	Q14686
TPPKEVSPDPSTTGA	GATA2	176	P23769
PPAGVVTPKSDAEEP	CABP4	21	P57796
SVSSPEPPKSVPVCE	CHAMP1	181	Q96JM3
LEEKSTTPPPAEPVS	G3BP2	221	Q9UN86
AKPHEVEPPSVTPDT	CMYA5	371	Q8N3K9
PTKTPSSSQEPPDEG	GON4L	1386	Q3T8J9
LEGPTPPPDSKSVSQ	DNAAF9	1041	Q5TEA3
TQPEEPVSPKPSPTF	ANK3	2186	Q12955
PPLEETETSPTKSPD	ANK3	3036	Q12955
TSETPEAAIPPGKQP	CAPRIN2	711	Q6IMN6
QTETEVELKSSPGPP	EML3	86	Q32P44
DPRVPSEGPKETPSS	BAG3	51	O95817
STEKTITPPEPEPTG	BCAS1	476	O75363
EESKPPIPTQVGPAT	PROCA1	181	Q8NCQ7
PSTSIKTEPVTDEPP	CREB3L2	121	Q70SY1
PTPTQPEELGPTSLK	PTX4	191	Q96A99
ALPKPPGTPVVTEST	PTPRD	321	P23468
GPRSVQSEPPTPKSE	PHACTR3	131	Q96KR7
SVTLEDVTPKKSPPP	FAN1	91	Q9Y2M0
ETEGPDFPSPSVPLK	SYTL1	151	Q8IYJ3
EPESKSEPRPPISSP	RAB11FIP1	516	Q6WKZ4
PDQKPEVAPSDPGTT	RPH3A	311	Q9Y2J0
GSSSPDTKVKPETPP	SRRM2	971	Q9UQ35
EEEEDPPLPTTPTSV	RSAD2	61	Q8WXG1
SSEPEPTPGAAKPET	SYNJ2	1206	O15056
PAPGTEEDTPLKPSA	FNBP4	751	Q8N3X1
PKPPGELTAESPQST	NHS	1546	Q6T4R5
VTTAKPEGPSDPPAL	KCNV2	81	Q8TDN2
PDTPPGTPLVSQDEK	PNKP	116	Q96T60
LETETSGPERPPEKP	HYPK	11	Q9NX55
SAEIPEGSPESPKDP	SSC5D	741	A1L4H1
VEPAPLKPTSEPTSG	PI4KB	6	Q9UBF8
TTPKEPAPTTTKEPA	PRG4	391	Q92954
EPAPTTTKEPAPTTT	PRG4	411	Q92954
KEPAPTTPKETAPTT	PRG4	606	Q92954
EELAPTTPEEPTPTT	PRG4	646	Q92954
TTPKEPAPTTPKETA	PRG4	691	Q92954
GTAPTTLKEPAPTTP	PRG4	711	Q92954
DKPAPTTPKETAPTT	PRG4	816	Q92954
TTPKETAPTTPKEPA	PRG4	821	Q92954
ETTSKDSHPPDLGPP	SETDB1	941	Q15047
ATPPEPLPTTTEDEG	ARAP1	96	Q96P48
PIKETEPPDSQGEPS	APC	1986	P25054
EKVAVSPTPPVSPEV	CEP164	561	Q9UPV0
PTTRGTPQTPKDDPA	CNNM1	816	Q9NRU3
VPPRTKSPTDDEVTP	PLEKHA6	771	Q9Y2H5
TESPPGAEAKPTSPT	ZFR2	366	Q9UPR6
VGKPPQDVTDDSPPS	SPEN	1211	Q96T58
TPAATTSPKESSEPP	RREB1	1116	Q92766
EDSGPPPVPKETVDS	SLC1A4	156	P43007
PPATETPGPEKAATD	SCARF2	821	Q96GP6
PPSKTVLPTVPESPE	ZC3H11A	96	O75152
TPSPTELGTEAPESP	TNXB	1356	P22105
EETETETTAPTPPAP	TNXB	1866	P22105
LTVPEEEKPSEPPTA	TNXB	1966	P22105
SPTSPTVEPEKPTRE	UBE2O	836	Q9C0C9
SPAEPSKSVPSLEGP	HIVEP3	756	Q5T1R4
PGDIDPTSVASPKDP	SUCO	251	Q9UBS9
PTSVASPKDPEDIPT	SUCO	256	Q9UBS9
PPSTEKEIDPTSIPT	RSRC1	276	Q96IZ7
PVSEPSVEKFSPPSE	ZC2HC1C	341	Q53FD0
PPSKSVLPTVPESPE	ZC3H11B	96	A0A1B0GTU1
SSEPSSPEPGKVNIP	ZEB1	641	P37275
EGPSESSSEPEPVVP	GTF3C2	261	Q8WUA4
PTKPFLAPETTSPGD	PLEKHO2	206	Q8TD55
VSQPSLVGSKEEPPP	WNK1	166	Q9H4A3
PVLPEETESSKPGPS	UBR5	2126	O95071
PGSKSTPPFSEPLEV	TNFRSF11A	366	Q9Y6Q6
EKPTIPSEKPTIPSE	ZAN	631	Q9Y493
PSEKPTIPSEKPTIS	ZAN	636	Q9Y493
TEKPTVPTEEPTTPT	ZAN	651	Q9Y493
EKPTTPTEKPTIPTE	ZAN	736	Q9Y493
EKPTIPTEKPTIPTE	ZAN	981	Q9Y493